| Literature DB >> 31310592 |
Clair Crewe1, Yi Zhu1, Vivian A Paschoal1, Nolwenn Joffin1, Alexandra L Ghaben1, Ruth Gordillo1, Da Young Oh1, Guosheng Liang2, Jay D Horton2,3, Philipp E Scherer1.
Abstract
The synthesis of lipid and sterol species through de novo lipogenesis (DNL) is regulated by two functionally overlapping but distinct transcription factors: the sterol regulatory element-binding proteins (SREBPs) and carbohydrate response element binding protein (ChREBP). ChREBP is considered to be the dominant regulator of DNL in adipose tissue (AT); however, the SREBPs are highly expressed and robustly regulated in adipocytes, suggesting that the model of AT DNL may be incomplete. Here we describe a new mouse model of inducible, adipocyte-specific overexpression of the insulin-induced gene 1 (Insig1), a negative regulator of SREBP transcriptional activity. Contrary to convention, Insig1 overexpression did block AT lipogenic gene expression. However, this was immediately met with a compensatory mechanism triggered by redox activation of mTORC1 to restore SREBP1 DNL gene expression. Thus, we demonstrate that SREBP1 activity sustains adipocyte lipogenesis, a conclusion that has been elusive due to the constitutive nature of current mouse models.Entities:
Keywords: Adipose tissue; Diabetes; Endocrinology; Metabolism; Signal transduction
Year: 2019 PMID: 31310592 PMCID: PMC6693888 DOI: 10.1172/jci.insight.129397
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708